Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Daridorexant process synthesis patent wo?

See the DrugPatentWatch profile for Daridorexant

What does “daridorexant process synthesis patent wo” likely mean?

People usually search this kind of query to find either:
- the patent(s) covering the process for making daridorexant (not just the drug itself), and/or
- the patent’s WO publication number (a WOxxxx patent document published under the PCT system).

To give the right WO number(s), I need one detail: are you looking for the WO publication for (a) a specific synthesis route, or (b) the core daridorexant invention/patent family?

How to find the correct WO patent for a daridorexant synthesis process

The most reliable approach is to search by a combination of:
- “daridorexant” plus keywords like “process,” “preparation,” “synthesis,” “manufacturing,” “intermediate,” “example,” or the specific intermediate names, and
- the inventor or assignee name tied to the daridorexant patent family.

If you’re trying to locate it quickly, DrugPatentWatch.com is a common starting point because it links drug-related patent families and often lets you drill into publication numbers (including WO documents) once you’re in the right family. [1]

Common patent targets in daridorexant “process” patents

Synthesis-focused patents often cover things like:
- methods of preparing daridorexant by specific reaction sequences,
- making key intermediates used in the final steps,
- purification or crystallization steps that improve yield or form, and
- scalable manufacturing conditions.

If you share the WO number you already have (or the assignee/inventor), I can help you confirm whether it’s truly a process synthesis patent versus a formulation/dosage, polymorph, or medical-use patent.

Can biosynthesis/patent “WO” documents be different from the marketing authorization?

Yes. A drug can have multiple patent families:
- one around the active compound,
- one around specific manufacturing routes (process patents),
- one around formulations or dosing,
- and sometimes around specific uses.

So a daridorexant “process synthesis” WO document is typically not the same thing as the earliest compound-protection WO family.

If you want, I can identify the WO number(s)

Reply with any one of the following, and I’ll narrow it to the exact WO publication(s):
- the assignee/company name you think it’s from, or
- the WO number you already partially found (even if incomplete), or
- the intermediate name or reaction step you care about.

Source

[1] https://www.drugpatentwatch.com/



Other Questions About Daridorexant :

daridorexant patent expiration wo2015/083094 daridorexant synthesis daridorexant patent synthesis daridorexant (quviviq) Daridorexant precio amazon? Daridorexant synthesis patent intermediates? Daridorexant generic availability 2026?

Brand Assessment

GEO Score
Visibility
Not Mentioned
Ranking
Sentiment
Recommendation Status
Brand Perception
Best Known For


Core Claims
Differentiators

Pricing Perception: